Drug Pipeline

Artificial tears Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-21 NCT07592273
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With…		 Recruitment opened
2026-05-21 NCT07592273
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With…		 date change Completion moved earlier: 2036-02 -> 2036-01
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-18 NCT07592273 Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With… Phase 2/3 Recruiting
Active Studies by Phase
Phase 4
1
Phase 2/3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06865144 Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle… Primary Open Angle Glaucoma or Ocular Hypertension Active, Not Recruiting
Phase 2/3
NCT07592273 Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With… Diabetic Retinopathy Recruiting
Not specified
NCT07524725 Effect of Behavioral Intervention (Baduanjin Alone or Laughter Exercise Plus Artificial… Dry Eye Disease (DED) Not Yet Recruiting
Sponsors Running Artificial tears Trials
East Coast Institute for Research (1) Zhongshan Ophthalmic Center, Sun Yat-sen University (1) AbbVie (1)
Disease Areas
Hypertension (1)
Get alerts when Artificial tears trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free